Frontline Dispatch Series: Dr. Wanda Barfield

Speaker: Wanda Barfield, MD, MPH, FAAP, RADM USPHS (ret.), at Centers for Disease Control (CDC)

Date: November 10, 2022 at 4:00PM - 5:00PM

Talk Title: Maternal and Infant Health Data Equity and Modernization: Are We There Yet?

Wanda Barfield, MD, MPH, FAAP, RADM USPHS (ret.) is the Director of the Division of Reproductive Health (DRH) within the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) at the Centers for Disease Control and Prevention (CDC). She is a retired Assistant Surgeon General in the U.S. Public Health Service. Dr. Barfield joined CDC in 2000 as part of its Epidemic Intelligence Service where she worked in neonatal and perinatal health. She was named Division Director in 2010.  Dr. Barfield’s research focuses on maternal/infant morbidity and mortality, early child health services utilization, improving access to risk-appropriate perinatal care, and advancing the quality of maternal, infant, and reproductive health data for public health action. She has published over 120 scientific articles in these areas. As DRH Director, Dr. Barfield has led efforts to provide optimal and equitable health to women, infants, and families through improved surveillance and applied public health research during the critical junctures of population health; pregnancy, infancy, and adolescence.  She has built and strengthened numerous strategic partnerships with multiple MCH organizations.  In addition, Dr. Barfield is an Associate Professor of Pediatrics with the Uniformed Services University of the Health Sciences and an Adjunct Assistant Professor at Emory University School of Medicine.  She is a Fellow with the American Academy of Pediatrics (AAP) and is the CDC liaison to the AAP Section on Neonatal-Perinatal Medicine (SoNPM) and Committee on Fetus and Newborn (COFN). She continues to do clinical work in neonatology, providing care to premature and other critically ill newborns.


Hopper RK, Abman SH, Elia EG, Avitabile CM, Yung D, Mullen MP, Austin ED, Bates A, Handler SS, Feinstein JA, Ivy DD, Kinsella JP, Mandl KD, Raj JU, Sleeper LA, . Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry. The Journal of pediatrics 2022.

Wang X, Zhang HG, Xiong X, Hong C, Weber GM, Brat GA, Bonzel CL, Luo Y, Duan R, Palmer NP, Hutch MR, Gutiérrez-Sacristán A, Bellazzi R, Chiovato L, Cho K, Dagliati A, Estiri H, García-Barrio N, Griffier R, Hanauer DA, Ho YL, Holmes JH, Keller MS, Klann MEng JG, L'Yi S, Lozano-Zahonero S, Maidlow SE, Makoudjou A, Malovini A, Moal B, Moore JH, Morris M, Mowery DL, Murphy SN, Neuraz A, Yuan Ngiam K, Omenn GS, Patel LP, Pedrera-Jiménez M, Prunotto A, Jebathilagam Samayamuthu M, Sanz Vidorreta FJ, Schriver ER, Schubert P, Serrano-Balazote P, South AM, Tan ALM, Tan BWL, Tibollo V, Tippmann P, Visweswaran S, Xia Z, Yuan W, Zöller D, Kohane IS, Avillach P, Guo Z, Cai T, . SurvMaximin: Robust federated approach to transporting survival risk prediction models. Journal of biomedical informatics 2022.

Torous J, Stern AD, Bourgeois FT. Regulatory considerations to keep pace with innovation in digital health products. NPJ digital medicine 2022.

Levy S, Wisk LE, Minegishi M, Ertman B, Lunstead J, Brogna M, Weitzman ER. Association of Screening and Brief Intervention With Substance Use in Massachusetts Middle and High Schools. JAMA network open 2022.

Nielsen M, Presti M, Sztupinszki Z, Jensen AWP, Draghi A, Chamberlain CA, Schina A, Yde CW, Wojcik J, Szallasi Z, Crowther MD, Svane IM, Donia M. Co-existing alterations of MHC class I antigen presentation and IFNγ signaling mediate acquired resistance of melanoma to post-PD-1 immunotherapy. Cancer immunology research 2022.